China
The crystal ball: Predictions for 2020
Industry experts weigh in as a range of macro factors promise to reshape markets across the region. Political, demographic, and scientific variables loom large
Chinese industrial internet platform gets $42m Series A
Xreacloud, an industrial internet-of-things (IoT) platform incubated by Chinese state-owned construction machinery manufacturer XCMG, has raised RMB300 million ($43 million) in Series A funding.
AIIB backs two energy, infrastructure funds
China-headquartered Asian Infrastructure Investment Bank (AIIB) is set to anchor two private equity funds, including an energy-focused vehicle, with a total commitment of $125 million.
China's KeChow Pharma gets $45m Series C
Shanghai Kechow Pharma, a Chinese small molecule targeted drug developer, has raised a $45 million Series C round led by Decheng Capital.
China fabrics platform Baibu raises $300m
Baibu, a Chinese B2B trading and services platform for the textiles and fabrics industry, has raised a $300 million Series D round led by DST Global.
China’s largest co-working player Ucommune files for US IPO
Ucommune, China’s largest co-working space player which is considered the local equivalent to troubled US operator WeWork, has filed for a US IPO.
Chinese drone maker EHang raises $40m in US IPO
Chinese drone manufacturer EHang traded flat on its NASDAQ debut following a $40 million IPO that priced at the bottom end of the indicative range.
Tencent Literature leads round for Chinese interactive filmmaker
AltStory, a Chinese interactive movie and television content company, has raised approximately RMB100 million ($14 million) in Series A funding led by China Literature, a listed unit of Tencent Holdings.
General Atlantic promotes China healthcare head
Lefei Sun, who helped establish and now leads General Atlantic’s healthcare and life sciences business in China, has been promoted to managing director.
2019 in review: Falling short
Fundraising, investment and exits in Asia are unlikely to match last year as pan-regional funds take a back seat, large-cap buyouts remain in short supply, growth-stage tech loses its edge, and IPOs flounder
Chinese space launch provider get $71m Series C
Chinese commercial space launch service provider LandSpace has raised a RMB500 million ($71 million) Series C led by the VC arm of Hong Kong-listed property developer Country Garden.
Deal focus: EQT fulfills Laobaixing's prescription
EQT spent 11 years helping Chinese pharmacy chain Laobaixing evolve from large-format laggard into a focused and efficient operator that meets the needs of modern customers. It has now exited with a 7.7x return
Chinese digital logistics player secures $14m Series A
Kalihulian - a China-based digital logistics platform that offers an Uber-style service for cargo freight - has raised RMB100 million ($14 million) in Series A funding led by Sino-Ocean Capital, an investment arm of property developer Sino-Ocean Group.
Centurium seeks $2.5b for second China fund
China-focused private equity firm Centurium Capital is back in the market looking to raise $2.5 billion for its second US dollar-denominated fund, barely six months after reaching a final close on its first.
ClearVue joins $74 million round for China’s Aibee
Chinese artificial intelligence (AI) start-up Aibee has raised RMB522 million ($74 million) in an extended Series A round led by ClearVue Partners and technology-focused Singularity Power Capital (SPC).
Deal focus: Kujiale embraces SaaS
Having struggled to get traction with consumers, Chinese online interior design player Kujiale turned its attentions to enterprise. International expansion is now on the agenda
Portfolio: Warburg Pincus and ESR
ESR, an Asia-focused warehousing platform seeded by Warburg Pincus, stole a march on its rivals by tapping into the rise of e-commerce in China. It is now looking to stay ahead of the curve
Prologis launches $1.7b China logistics fund
US-based logistics and supply chain investor Prologis has established a $1.7 billion China fund as part of a broader country expansion.
Local GPs commit $71m to China biotech player
EOC Pharma, a Chinese biotech developer focused on cancer treatments, has closed a RMB500 million ($71 million) Series C round raised from a group of local private equity investors.
Chinese data center operator raises $3.7b Series A
Tenglong Group, a data center operator based in Beijing, has raised a RMB26 billion ($3.7 billion) Series A round led by Morgan Stanley Private Equity Asia and state-owned China Nanshan Development Group.
GLP launches $2.1b China logistics fund
GLP, a private equity-owned warehouse operator based in Singapore, has set up a China logistics fund at RMB15 billion ($2.1 billion).
Chinese biopharma start-up raises $43m Series B
Chinese cancer and autoimmune disease therapy developer Clover Biopharmaceuticals has raised a $43 million Series B round led by local VC Lapam Capital and US private equity firm Delos Capital.
China’s Loyal Valley closes second US dollar fund at $465m
China’s Loyal Valley Capital has closed its second US dollar-denominated fund at $465 million. The target was $400 million with a hard cap of $440 million.
FountainVest, Primavera invest $557m in China pharmacy chain
FountainVest Partners and Primavera Capital have paid $557 million for a 24.78% stake in Chinese pharmacy chain Laobaixing. It will provide a full exit for EQT Partners.